MedTrace Logo

Web-Based Advance Care Planning for Patients With Advanced Cancer

NCT07712237 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2026-07-21

No results posted yet for this study

Summary

The goal of this clinical trial is to determine whether a web-based advance care planning (ACP) intervention can reduce preferences for aggressive life-sustaining treatments among patients with advanced cancer.

The main questions it aims to answer are:

* Does a web-based ACP intervention reduce preferences for aggressive life-sustaining treatments among patients with advanced cancer?
* Does a web-based ACP intervention support informed medical decision-making regarding future care?

Researchers will compare a web-based ACP intervention plus a Patient Right to Autonomy Act leaflet with a Patient Right to Autonomy Act leaflet alone to determine whether the web-based ACP intervention is more effective in reducing preferences for aggressive life-sustaining treatments.

Participants will:

* Be randomly assigned to either an intervention group or a control group
* Receive either a web-based ACP educational program plus a Patient Right to Autonomy Act leaflet, or a Patient Right to Autonomy Act leaflet alone
* Complete questionnaires at baseline, immediately after the intervention, and one week after the intervention

Conditions

Interventions

BEHAVIORAL

Web-Based Advance Care Planning Program

A web-based educational program designed to improve advance care planning knowledge, promote informed decision-making, and facilitate discussions regarding future medical care among patients with advanced cancer.

OTHER

Patient Right to Autonomy Act Leaflet

An educational leaflet providing information about the Patient Right to Autonomy Act and advance care planning.

Sponsors & Collaborators

  • Tri-Service General Hospital (TSGH)

    lead OTHER

Principal Investigators

  • Hsueh-Hsing Pan, PhD · National Defense Medical University

  • Yu-Shiue Lin · National Defense Medical University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-16
Primary Completion
2024-01-22
Completion
2024-01-22

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07712237 on ClinicalTrials.gov